While the use of elivaldogene autotemcel (eli-cel; Skysona) gene therapy has demonstrated long-term efficacy in patients with ...
Coherus BioSciences Inc (CHRS) reports a 10% increase in total revenue and significant progress in its oncology portfolio, ...
Following a landmark case this summer, the question of how to contain the growing silicosis epidemic is far thornier than it ...